Close
Back to PBYI Stock Lookup

Puma Biotech (PBYI) – Major News

Feb 29, 2024 04:14 PM Puma Biotech (PBYI) Tops Q4 EPS by 1c, offers outlook
Nov 2, 2023 04:55 PM Puma Biotech (PBYI) Tops Q3 EPS by 10c; Offers FY23 Revenue Guidance
Aug 3, 2023 04:52 PM Puma Biotech (PBYI) Tops Q2 EPS by 9c ; Offers Guidance
May 4, 2023 04:49 PM Puma Biotech (PBYI) Tops Q1 EPS by 17c
Mar 2, 2023 04:32 PM Puma Biotech (PBYI) Misses Q4 EPS by 12c; Offers Guidance
Mar 3, 2022 04:21 PM Puma Biotech (PBYI) Tops Q4 EPS by 31c
Aug 5, 2021 05:51 PM Puma Biotech (PBYI) Tops Q2 EPS, Revenues Miss
Feb 25, 2021 05:30 PM Puma Biotech (PBYI) Tops Q4 EPS by 15c
Aug 6, 2020 05:53 PM Puma Biotech (PBYI) Tops Q2 EPS by 65c, Revenues Miss
May 7, 2020 06:00 PM Puma Biotech (PBYI) Tops Q1 EPS by 53c, Revenues Beat
Feb 20, 2020 04:16 PM Puma Biotech (PBYI) Reports Q4 EPS of $0.01
Nov 6, 2019 06:03 PM Puma Biotech (PBYI) Tops Q3 EPS by 59c, Revenues Miss
Aug 8, 2019 04:12 PM Puma Biotech (PBYI) Tops Q2 EPS by 43c
May 9, 2019 05:13 PM Puma Biotech (PBYI) Tops Q1 EPS by 89c
Feb 28, 2019 04:11 PM Puma Biotech (PBYI) Misses Q4 EPS by 3c
Nov 1, 2018 04:17 PM Puma Biotech (PBYI) Reports Q3 EPS of $0.17
Aug 9, 2018 04:14 PM Puma Biotech (PBYI) Tops Q2 EPS by 9c
May 9, 2018 04:10 PM Puma Biotech (PBYI) Tops Q1 EPS by 24c
Mar 1, 2018 04:16 PM Puma Biotech (PBYI) Tops Q4 EPS by 95c, Beat on Revenues
Nov 9, 2017 04:16 PM Puma Biotech (PBYI) Tops Q3 EPS by 113c
Jul 17, 2017 04:32 PM Puma Biotech's (PBYI) Neratinib Receives FDA Approval for Extended Adjuvant Treatment of Early Stage HER2-positive Breast Cancer
May 24, 2017 01:31 PM Puma Biotech (PBYI) Confirms FDA AdCom Backing for Neratinib
May 24, 2017 11:47 AM Puma Biotech's (PBYI) Neratinib Wins Backing From FDA Panel
Apr 17, 2017 08:04 AM Puma Biotech (PBYI) AdCom Meeting for Neratinib Scheduled for May 24
Aug 9, 2016 04:35 PM Puma Biotech (PBYI) Posts Q2 adj.-Loss of $1.17/Share
May 10, 2016 04:19 PM Puma Biotech (PBYI) Tops Q1 EPS Views
Feb 29, 2016 04:24 PM Puma Biotech (PBYI) Reports Q4 Loss of $1.23/Share
Dec 11, 2015 10:47 AM Puma Biotech (PBYI) Announces Three-Year DFS Data from PB272 Phase 3 as Adjuvnant Breast Cancer Treatment
Aug 10, 2015 04:21 PM Puma Biotech (PBYI) Reports Q2 Loss of $1.13
Jun 1, 2015 11:27 AM Puma Biotech (PBYI) Announces Statistically Significant Data from PB272 Phase 3 in Breast Cancer
Aug 11, 2014 04:51 PM Puma Biotechnology, Inc. (PBYI) Posts Q2 Loss of $1.05/Share
Jul 22, 2014 04:53 PM Puma Biotechnology (PBYI) Surges Over 200% on Statistically Significant Phase III PB272, Amended Licensing Deal with Pfizer
Mar 3, 2014 04:19 PM Puma Biotechnology, Inc. (PBYI) Posts Q4 Loss of 46c/Share
Apr 1, 2013 04:42 PM Puma Biotechnology, Inc. (PBYI) Reports Q4 Loss of 25c
Nov 14, 2012 08:31 AM Puma Biotechnology, Inc. (PBYI) Reports Q3 Loss of $1.29

Back to PBYI Stock Lookup